Intec Pharma's common stock is $730K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Intec Pharma (NTEC) currently reports a common stock of $730K as of March 2021. That compares with $730K in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Intec Pharma's common stock history and peer comparisons.
Intec Pharma's common stock was unchanged from $730K to $730K — essentially flat versus a year earlier (period ending March 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Intec Pharma reported $730K in common stock as of March 2021. That compares with $730K in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $730K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Intec Pharma, and consider following NTEC for alerts when major investors trade the stock.
Intec Pharma is classified in the Healthcare sector. On common stock, it currently shows $730K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NTEC with unrelated industries.